# J-Valve Transfemoral Pivotal Study

Study · id `cardio:ct-nct06455787` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06455787](<https://clinicaltrials.gov/study/NCT06455787>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06455787

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 194 participants.

## Technical summary

Registry record NCT06455787. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-17 (actual); primary completion 2028-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 194 participants (planned count; ClinicalTrials.gov record NCT06455787, source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)
- Started: 2024-10-17 (actual) (ClinicalTrials.gov record NCT06455787, source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)
- Primary completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT06455787, source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)
- Completion: 2032-02 (anticipated) (ClinicalTrials.gov record NCT06455787, source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)
- Countries: United States; Canada; France; Japan; United Kingdom (ClinicalTrials.gov record NCT06455787, source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06455787-2026-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: J-Valve Transfemoral Pivotal Study
- Acronym: JOURNEY
- Condition: Aortic Valve Regurgitation
- Condition: Aortic Valve Disease Mixed
- Intervention (Device): J-Valve Transfemoral (TF) System
- Lead sponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Lead sponsor class: INDUSTRY
- Collaborator: Minneapolis Heart Institute Foundation
- Collaborator class: OTHER
- Collaborator: Cardiovascular Research Foundation, New York
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as a collaborator: Minneapolis Heart Institute Foundation (`cardio:org-minneapolis-heart-institute-foundation`)
- Registry lists this organization as a collaborator: Cardiovascular Research Foundation, New York (`cardio:org-cardiovascular-research-foundation-new-york`)

## Provenance

Content hash: 25722b7a09c9c35c2c8f2aa3ddfaa6d2d0d679516eddbb16c9568abfaf388f28
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
